2021
DOI: 10.1016/j.neubiorev.2020.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(30 citation statements)
references
References 252 publications
5
25
0
Order By: Relevance
“…An investigation in the human VS might be particularly challenging since the animal literature has highlighted the presence of hedonic "coldspots" in the Nucleus Accumbens shell, which are typically activated by the same ligands as the hedonic hotspots (e.g., opioids), but inhibit-rather than amplify-hedonic expressions (Pecina and Berridge, 2005;Castro and Berridge, 2014). More generally, the impact of manipulations of opioid and dopamine manipulations on human reward processing appears to be modulated by several factors, increasing the complexity of these investigations in humans (Webber et al, 2020;Meier et al, 2021). Finally, it is worth noting that we did not determine our sample size by means of a power analysis.…”
Section: Discussionmentioning
confidence: 99%
“…An investigation in the human VS might be particularly challenging since the animal literature has highlighted the presence of hedonic "coldspots" in the Nucleus Accumbens shell, which are typically activated by the same ligands as the hedonic hotspots (e.g., opioids), but inhibit-rather than amplify-hedonic expressions (Pecina and Berridge, 2005;Castro and Berridge, 2014). More generally, the impact of manipulations of opioid and dopamine manipulations on human reward processing appears to be modulated by several factors, increasing the complexity of these investigations in humans (Webber et al, 2020;Meier et al, 2021). Finally, it is worth noting that we did not determine our sample size by means of a power analysis.…”
Section: Discussionmentioning
confidence: 99%
“…Dopamine RPE signaling in the dorsal striatum -observed both in the firing patterns of dopamine neurons and in dopamine concentration changes in the striatum -is essential for reinforcement learning [34][35][36]. While this proposal has been directly tested in animals using optogenetics [35], pharmacological manipulations of dopaminergic RPE signaling in the dorsal striatum rigorously in humans has been difficult (e.g., dopamine drugs have differing effects on various brain regions and reward phases [37], and no D1 agonist drugs are available for human use). Motivated by evidence demonstrating that 10-Hz rTMS to the left DLPFC can enhance dopaminergic activity in the dorsal striatum [3], we investigated the impact of rTMS on behavioral and computational measures of striatal-based reinforcement learning in healthy subjects.…”
Section: Discussionmentioning
confidence: 99%
“…However, while animal models consistently demonstrate that dopamine signals code RPEs ( Schultz, 2016a ), research examining pharmacological manipulations of dopamine in healthy participants offer mixed findings. While dopamine antagonism has been demonstrated to consistently decrease reward learning, dopamine antagonism and dietary manipulations of dopamine offer mixed results ( Webber et al, 2021 ). These discrepancies could be due to a number of factors including drug manipulations, dosing regimens, or the possibility that there is an optimal level of dopamine for reward-related learning, with increases beyond this level impairing reward-related functioning ( Vaillancourt et al, 2013 ).…”
Section: Antidepressant Drugs and Predictive Processesmentioning
confidence: 99%